A Multicenter, Randomized, Double-blind, Placebo control

Project: Research project

Project Details

Description

A Multicenter, Randomized, Double-blind, Placebo controlled, Phase 2 Study Evaluating the Safety and Efficacy of Different Doses of IW-1973 over 12 Weeks in Patients with Heart Failure with Preserved Ejection Fraction (CAPACITY HFpEF)
StatusActive
Effective start/end date1/1/181/30/21

Funding

  • IRONWOOD PHARMACEUTICALS, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.